News Brief

Sanofi-Aventis Awards Euro RSCG Worldwide Drug Account

Nov 17, 2006, 7:00 AM
  • Comment
  • Recommend
Subscribe to MediaDailyNews

Tags

Sanofi-Aventis, the world's third-largest pharmaceutical company, has named Euro RSCG Worldwide its global agency in charge of all communications for Lovenox/Clexane, a leading product for thrombosis treatment, and Lantus and Apidra, which treat diabetes. This is the first global pharmaceutical client for the company. Sanofi-Aventis has enlarged its partnership with Euro RSCG Life by awarding the agency the responsibility of launching all communications programs for all new brands in these two therapeutic domains.

  • Comment
  • Recommend

Be the first to comment on "Sanofi-Aventis Awards Euro RSCG Worldwide Drug Account"

Leave a Comment

Sign in to leave a comment. Don't have an account? Join Now

Recent MediaDailyNews Articles

>> MediaDailyNews Archives